Oxeia Biopharmaceuticals Inc
Biotechnology Research in United States
Overview
Oxeia Biopharmaceuticals is a clinical-stage biotech company developing new, innovative therapeutics for mild traumatic brain injury (mTBI), known as concussion, and related neuro-metabolic dysfunction. The company has a drug, OXE103, that began a Phase 2 clinical trial in the fall of 2020. To date there are few other studies aimed at treating these patients.
Tagline
Oxeia Biopharmaceuticals develops novel therapeutics for patients with concussions. Because rest is not enough
EMPLOYEES
2-10 employees
FOUNDED
2014
HQ
Boston, Massachusetts
TYPE
Privately Held
Location
- Street
- 361 Newbury St
- City
- Boston
- Region
- Massachusetts
- Postal code
- 02115
- Country
- United States
Email patterns
See email patterns for Oxeia Biopharmaceuticals Inc
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
oxeiabiopharma.com is the website of Oxeia Biopharmaceuticals Inc.
What is the industry of the company?
Oxeia Biopharmaceuticals Inc (oxeiabiopharma.com) is in the Biotechnology Research industry.
When was the company founded?
Oxeia Biopharmaceuticals Inc (oxeiabiopharma.com) was founded in 2014.
How many employees does the company have?
Oxeia Biopharmaceuticals Inc (oxeiabiopharma.com) has 2-10 employees.
What is the company type?
The company type of Oxeia Biopharmaceuticals Inc (oxeiabiopharma.com) is Privately Held.
Where is the company headquartered?
Oxeia Biopharmaceuticals Inc (oxeiabiopharma.com) is headquartered in Boston, Massachusetts.
What is the address of the company?
The address of Oxeia Biopharmaceuticals Inc (oxeiabiopharma.com) is 361 Newbury St, Boston, Massachusetts, 02115, United States.
What are the social media accounts of the company?
The social media account of Oxeia Biopharmaceuticals Inc (oxeiabiopharma.com) is LinkedIn.
Social media